About Cirsium Biosciences
Operator of a research and development biotechnology company intended for the production of gene therapies. The company uses whole plants as the production platform for developing viral vector manufacturing technologies, enabling clients to address current issues with cost, capacity, scalability, and speed for the production of gene therapies.
Company details
Funding
Total raised
$10.6M
Last stage
Seed
Investors
Founders
Daniel Gibbs
PhD in Anatomy and Physiology from the University of Dundee; 20+ years in viral vector and gene therapy development; previously Senior Director at Locanabio and the Salk Institute. Co-founded Cirsium Biosciences (formerly Vecprobio, Inc.) in 2019.
LinkedInJake Connors
BS in Biomedical Sciences from UCSD; background in molecular neuroscience, controlled environment agriculture, and viral vector manufacturing. Co-founded Cirsium Biosciences in 2019.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.